Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects
Two types of olaparib tablets were bioequivalent under both fasting and fed condition, and were generally well tolerated in healthy Chinese male subjects.
Authors
- Jingxuan Wu (ORCID: https://orcid.org/0000-0002-3128-7601)
- Jingcheng Chen (ORCID: https://orcid.org/0000-0001-6269-072X)
- Ruihua Dong (ORCID: https://orcid.org/0000-0003-3463-5023)
- Xiaoru Wang (ORCID: https://orcid.org/0000-0002-8554-8045)
- Xueyuan Zhang
- Nini Guo (ORCID: https://orcid.org/0009-0001-0598-9589)
- Yuqin Song (ORCID: https://orcid.org/0000-0002-5118-0625)
- Yingying Yang (ORCID: https://orcid.org/0000-0003-2919-9853)
Institutions
- Capital Medical University (CN)
- Shijiazhuang Yiling Pharmaceutical (China) (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/dddt.s481481
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00